Furthermore, genetic inactivation of KLF4 blocks the formation of CCM lesions and abrogates the mortality of mice with endothelial-specific ablation of KRIT1 by 75% [104]. The gene discussed is KRIT1; the disease is cerebral cavernous malformation.